⌘K

Login Start Free

Home/Filings/4/0001209191-21-010674

4//SEC Filing

Verstandig Grant 4

Accession 0001209191-21-010674

CIK 0001538210other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 2:55 PM ET

Size

5.2 KB

Accession

0001209191-21-010674

Insider Transaction Report

Form 4

Period: 2021-02-11

NexImmune, Inc.NEXI

Verstandig Grant

Director

Transactions

Award
Stock Option (right to buy)
2021-02-11+39,096→ 39,096 total
Exercise: $17.00Exp: 2031-02-11→ Common Stock (39,096 underlying)

Footnotes (1)

[F1]This stock option will vest and become exercisable in equal monthly installments over a 36 month period.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1

filerCIK 0001843817

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 2:55 PM ET
Size: 5.2 KB

View on SEC.gov